ALKERMES | Utile Per Azione

Prezzo Delle Azioni
31.95
Cambio Giornaliero
-0.07 -0.22%
Mensile
0.63%
Annuale
-10.00%
Q1 Previsione
32.16

Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q4 Dec/2025 0.42 1.05 Feb/25 2026
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28 2025
FY2025Q2 Jun/2025 0.52 0.39 0.72 Jul/29 2025
FY2025Q1 Mar/2025 0.13 0.39 0.43 May/01 2025
FY2024Q4 Dec/2024 1.05 0.75 0.22 Feb/12 2025




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Acadia Pharmaceuticals USD 0.42 0.26 2025-09
ALKERMES USD 0.49 0.03 2025-09
Amgen USD 5.29 0.35 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.12 1.32 2025-09
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Coherus Biosciences USD -0.35 0.07 2025-03
Eli Lilly USD 7.54 0.52 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Heron Therapeutics USD -0.03 0.03 2024-09
Ionis Pharmaceuticals USD -0.8 1.5 2025-09
J&J USD 2.46 0.34 2025-12
Malin Corporation EUR 0 0 2024-12
Merck USD 2.04 0.54 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Otsuka Holdings JPY 124.25 110.44 2025-12
Ovoca Bio EUR -0.07 0.04 2022-06
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12


ALKERMES Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.